tiprankstipranks
Infinity Pharmaceuticals (INFIQ)
OTHER OTC:INFIQ
US Market

Infinity Pharmaceuticals (INFIQ) Income Statement

Compare
924 Followers

Infinity Pharmaceuticals Income Statement

Last quarter (Q2 2023), Infinity Pharmaceuticals's total revenue was $583.00K, a decrease of -20.25% from previous quarter. In Q2, Infinity Pharmaceuticals's net income was $-9.96M. See Infinity Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.59M$ 1.86M$ 1.72M$ 3.05M
Gross Profit
$ 1.03M$ 738.00K$ 682.00K$ -4.26M
Operating Expenses
$ 45.87M$ 45.82M$ 39.18M$ 41.41M
Depreciation and Amortization
$ 458.00K$ 480.00K$ 483.00K$ 219.00K
EBITDA
$ -43.73M$ -44.60M$ -37.56M$ -44.33M
Operating Income
$ -44.84M$ -45.08M$ -38.50M$ -45.66M
Other Income/Expenses
$ 475.00K$ -179.00K$ -2.00M$ -1.45M
Pretax Income
$ -44.37M$ -45.26M$ -40.49M$ -47.11M
Net Income
$ -44.37M$ -45.26M$ -40.49M$ -47.06M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -0.50$ -0.53$ -0.68$ -0.83
Diluted EPS
$ -0.50$ -0.53$ -0.68$ -0.83
Weighted Average Shares Outstanding
89.25M 85.60M 59.86M 56.98M
Weighted Average Shares Outstanding (Diluted)
89.25M 85.60M 59.86M 56.98M
Currency in USD

Infinity Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis